Opinion
Published on 02 Jun 2015
LightSNiP assay is a good strategy for pharmacogenetics test
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00114
- 5,526 views
- 5 citations
Type at least 3 characters
551 articles
Articles
Original Research
Published on 15 Apr 2015
Identifying genes that mediate anthracyline toxicity in immune cells
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00062
- 4,296 views
- 4 citations
Perspective
Published on 26 Mar 2015
Whole genome sequencing in pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00061
- 11,413 views
- 41 citations
Mini Review
Published on 23 Mar 2015
Genetic determinants for methotrexate response in juvenile idiopathic arthritis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00052
- 8,113 views
- 16 citations
Mini Review
Published on 08 Dec 2014
Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00265
- 13,581 views
- 58 citations
Original Research
Published on 16 Sep 2014
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00210
- 6,701 views
- 14 citations
Perspective
Published on 19 Aug 2014
Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00188
- 5,193 views
- 7 citations
Perspective
Published on 08 Jul 2014
Relevance of G-quadruplex structures to pharmacogenetics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00160
- 7,492 views
- 28 citations
Review
Published on 09 May 2014
Pharmacogenomics of human P450 oxidoreductase
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00103
- 13,167 views
- 74 citations
Hypothesis and Theory
Published on 26 Nov 2013
Current clinical evidence on pioglitazone pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00147
- 9,130 views
- 21 citations
Review
Published on 06 Nov 2012
Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00191
- 8,220 views
- 74 citations
Opinion
Published on 17 Oct 2012
Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00183
- 7,449 views
- 9 citations
Perspective
Published on 20 Aug 2012
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00152
- 10,736 views
- 38 citations
Original Research
Published on 21 May 2012
Physiologically-based pharmacokinetic modeling of tamoxifen and its metabolites in women of different CYP2D6 phenotypes provides new insight into the tamoxifen mass balance
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00092
- 17,288 views
- 32 citations
Methods
Published on 30 Mar 2012
Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00054
- 8,721 views
- 1 citation
Perspective
Published on 19 Jan 2012
Trends in Qualifying Biomarkers in Drug Safety. Consensus of the 2011 Meeting of the Spanish Society of Clinical Pharmacology
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00002
- 6,063 views
- 12 citations